Koyfin Home > Directory > Health Care > Antares Pharma > Long-Term Investments

Antares Pharma Long-Term Investments Chart (ATRS)

Antares Pharma annual/quarterly Long-Term Investments from 2011 to 2015.
  • Antares Pharma Long-Term Investments for the quarter ending September 09, 2015 was $3m a -99.84% decrease of -3m year over year
  • Antares Pharma Long-Term Investments for the last 12 months ending September 09, 2015 was $3m a -99.84% decrease of -3m year over year
  • Antares Pharma Annual Long-Term Investments for 2013 was $6m a -99.99% decrease of -6m from 2012
  • Antares Pharma Annual Long-Term Investments for 2012 was $12m a 74.81% increase of 9m from 2011
  • Antares Pharma Annual Long-Term Investments for 2011 was $3m
Other Cash Flow Metrics:
  • Antares Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $0m a -9,658.63% increase of 8m year over year
  • Antares Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $0m a -10,730.73% increase of 6m year over year
  • Antares Pharma Total Revenue for the quarter ending December 12, 2018 was $19m a 32.51% increase of 6m year over year
View Chart On Koyfin

Quarterly ATRS Long-Term Investments Data

09/2015$3m
06/2015$9m
03/2014$3m
12/2013$6m
06/2013$6m
03/2013$12m
12/2012$12m
09/2012$3m
06/2012$3m
03/2012$3m

Annual ATRS Long-Term Investments Data

2013$6m
2012$12m
2011$3m